Prostate News and Research

RSS

Researchers identify gene defect in mice that causes cyclical hair loss and skin cancer

Researchers at Jefferson Medical College and at the Wadsworth Center in New York have identified a gene defect in mice resulting in a range of abnormalities, from cyclical hair loss and skin cancer to severe problems in normal skin development.

4 Oct 2005

Rapid weight gain between the ages of 25 and 40 doubles likelihood of prostate cancer recurrence

Men who gain weight rapidly between the ages of 25 and 40 are twice as likely to have recurrence of prostate cancer after surgery as men without rapid rates of weight gain, researchers from University of Texas M. D. Anderson Cancer Center reported in the October 1 issue of "Clinical Cancer Research."

4 Oct 2005

PSA doubling time is an important indicator of how well a patient will recover from prostate cancer

The clinical outcome for prostate cancer patients who have been treated with hormone therapy and radiation therapy can usually be determined by how rapidly their prostate specific antigen level rises following treatment

3 Oct 2005

Development of aggressive forms of prostate cancer may be influenced by environmental effects that occur early in life

How heavy a man is at the time he is diagnosed with prostate cancer, as well as his history of weight gain, appear to play significant roles in how aggressive his cancer may become, say researchers at the University of Texas M. D. Anderson Cancer Center.

3 Oct 2005

Chicken virus helps develop novel vaccines

Researchers at the University of South Australia are developing novel vaccines by using a chicken virus to either stimulate or suppress the body's immune system.

28 Sep 2005

Veggies reduce the risk of developing lung cancer in smokers

Eating vegetables and other foods that have weak estrogen-like activity appears to reduce the risk of developing lung cancer in smokers - as well as in non-smokers, say researchers at The University of Texas M. D. Anderson Cancer Center.

27 Sep 2005

Pomegranate juice shows major promise to combat prostate cancer

The juice of the pomegranate, say researchers at University of Wisconsin Medical School, shows major promise to combat prostate cancer - the most common invasive cancer and the second-leading cause of cancer death in American men.

27 Sep 2005

22 biomarkers that provide a more accurate screening for prostate

Researchers at the University of Michigan Comprehensive Cancer Center have identified a panel of 22 biomarkers that together provide a more accurate screening for prostate cancer than the current prostate specific antigen, or PSA, test.

22 Sep 2005

Next generation of effective viral-based therapies for cancer

Researchers at Columbia University Medical Center continue to make strides in their work to develop the next generation of effective viral-based therapies for cancer.

21 Sep 2005

Gene mutation may increase the risk of prostate cancer up to three times in African-American

Researchers have identified a gene mutation that may increase the risk of prostate cancer up to three times in African-American men with a family history of the disease.

20 Sep 2005

High-fat fare increases risk of heart disease for hospital staff and visitors

Nutrition scientists with the Physicians Committee for Responsible Medicine (PCRM) have conducted a nationwide survey to determine if hospital cafeterias and restaurants are meeting the need for low-fat, cholesterol-free foods that can help people maintain a healthy weight and prevent heart disease, diabetes, and some cancers.

19 Sep 2005

PSA remains the best measure of the likelihood of prostate cancer recurrence after surgery

Despite recent claims by some urologists that measuring the blood protein prostate-specific antigen (PSA) may not be effective in predicting risk of prostate cancer, a Johns Hopkins study of more than 2,000 men confirms that PSA remains the best measure of the likelihood of cancer recurrence after surgery.

19 Sep 2005

Study points to importance of MYC gene in cancer progression

The cancer gene MYC is among the most commonly overexpressed oncogenes in human cancers. Most human cancers demonstrate high levels of MYC or its biological partners, including those of the breast, ovaries, lung, prostate, and skin, as well as leukemias and lymphomas.

19 Sep 2005

Prostate News and Research

Researchers identify gene defect in mice that causes cyclical hair loss and skin cancer

Rapid weight gain between the ages of 25 and 40 doubles likelihood of prostate cancer recurrence

PSA doubling time is an important indicator of how well a patient will recover from prostate cancer

Development of aggressive forms of prostate cancer may be influenced by environmental effects that occur early in life

Chicken virus helps develop novel vaccines

Veggies reduce the risk of developing lung cancer in smokers

Pomegranate juice shows major promise to combat prostate cancer

22 biomarkers that provide a more accurate screening for prostate

Next generation of effective viral-based therapies for cancer

Gene mutation may increase the risk of prostate cancer up to three times in African-American

High-fat fare increases risk of heart disease for hospital staff and visitors

PSA remains the best measure of the likelihood of prostate cancer recurrence after surgery

Study points to importance of MYC gene in cancer progression

Molecular pathway in mice that makes prostate cells vulnerable to cancer-causing oxygen damage

Low-fat, plant-based diet is more effective at helping women lose weight

Inhaled-insulin drug Exubera - monitoring programme to be launched by Pfizer

Double whammy of vitamin D and anti-inflammatory zaps prostate cancer cells

Prostate cancer manipulates an important group of signaling proteins called Wnts to establish itself in bone

Men with breast cancer gene at risk of pancreatic and prostate cancers

Mutation in the BRAC2 breast cancer gene may also increase the risk of bone and throat cancers

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News